Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|10|1|91-106

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.10, Iss.1, 2018-01, pp. : 91-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange‐Nielsen deafness syndrome

By  

EMBO Molecular Medicine, Vol. 7, Iss. 8, 2015-08 ,pp. : 1077-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology

By  

EMBO Molecular Medicine, Vol. 7, Iss. 4, 2015-04 ,pp. : 394-410

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is nicotine replacement therapy overvalued in smoking cessation? Analysis of smokers' and quitters' communication in social media

By  

Health Expectations (Electronic), Vol. 18, Iss. 6, 2015-12 ,pp. : 2962-2977

John Wiley & Sons Inc

Access to resources Recommend Favorite

Applying the Behavioural Family Therapy Model in Complex Family Situations

By Jhadray Rubina   Fadden Gráinne   Atchison Martin   Conneely Paula   Danks Julia   Lee Alison   Mansell Chris  

Social Sciences, Vol. 4, Iss. 2, 2015-06 ,pp. : 459-468

MDPI

Access to resources Recommend Favorite

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

By  

EMBO Molecular Medicine, Vol. 7, Iss. 9, 2015-09 ,pp. : 1211-1228

John Wiley & Sons Inc

Access to resources Recommend Favorite